Clin2
NCT07110532Likely a fitRecruiting

A study of flu virus exposure in healthy adults

Influenza

Part of Infections, Lungs & breathing clinical trials.

This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
90 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are in good general health, with no chronic conditions that need daily medication (like asthma, diabetes, or heart disease).
  • You are a non-smoker or only smoke occasionally (e.g., no more than 4 cigarettes a week).
  • You agree to stay in the research unit for at least 6 days and take antiviral medications if needed.
  • You have not had a flu vaccine in the last 4 months.
  • You are not pregnant, breastfeeding, and agree to use birth control if you could become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07703514Not yet recruiting· Phase 1
Experimental flu vaccine safety study

This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.

Baltimore, Maryland
NCT07215858Recruiting· Phase 2
Testing a new flu vaccine against H1N1 flu

This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.

Bethesda, Maryland
NCT05332899Recruiting· Phase 1
Flu challenge study in healthy adults to test an investigational approach

This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.

Atlanta, Georgia
NCT06753474Recruiting· Phase 1
Flu challenge study for healthy adults

This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.

Atlanta, Georgia
NCT07503405Not yet recruiting· Phase 2
Testing a new flu medicine with a controlled flu infection

This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.

London
NCT06667063Recruiting
Immune response study for COVID-19 and flu

This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.

Wuhan, Hubei

Hear when a new Influenza trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.